دورية أكاديمية
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review.
| العنوان: | Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review. |
|---|---|
| المؤلفون: | Young, Katherine G, McInnes, Eram Haider, Massey, Robert J, Kahkoska, Anna R, Pilla, Scott J, Raghavan, Sridharan, Stanislawski, Maggie A, Tobias, Deirdre K, McGovern, Andrew P, Dawed, Adem Y, Jones, Angus G, Pearson, Ewan R, Dennis, John M |
| المصدر: | Commun Med (Lond) ; ISSN:2730-664X ; Volume:3 ; Issue:1 |
| بيانات النشر: | Nature Publishing Group |
| سنة النشر: | 2023 |
| المجموعة: | PubMed Central (PMC) |
| الوصف: | A precision medicine approach in type 2 diabetes requires the identification of clinical and biological features that are reproducibly associated with differences in clinical outcomes with specific anti-hyperglycaemic therapies. Robust evidence of such treatment effect heterogeneity could support more individualized clinical decisions on optimal type 2 diabetes therapy. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://doi.org/10.1038/s43856-023-00359-wTest; https://pubmed.ncbi.nlm.nih.gov/37794166Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551026Test/ |
| DOI: | 10.1038/s43856-023-00359-w |
| الإتاحة: | https://doi.org/10.1038/s43856-023-00359-wTest https://pubmed.ncbi.nlm.nih.gov/37794166Test https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551026Test/ |
| حقوق: | © 2023. Springer Nature Limited. |
| رقم الانضمام: | edsbas.2BB5F973 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1038/s43856-023-00359-w |
|---|